Citadel Advisors’s Chimerix, Inc. CMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-49,300
Closed -$420K 15761
2025
Q1
$420K Sell
49,300
-63,700
-56% -$351K ﹤0.01% 8866
2024
Q4
$393K Buy
113,000
+79,100
+233% +$112K ﹤0.01% 9092
2024
Q3
$31.5K Sell
33,900
-14,200
-30% -$12.7K ﹤0.01% 12386
2024
Q2
$42.1K Buy
48,100
+29,200
+154% +$27.7K ﹤0.01% 11946
2024
Q1
$20K Buy
18,900
+12,300
+186% +$12.8K ﹤0.01% 13013
2023
Q4
$6.35K Buy
6,600
+1,700
+35% +$1.65K ﹤0.01% 13357
2023
Q3
$4.7K Sell
4,900
-8,000
-62% -$8.71K ﹤0.01% 13461
2023
Q2
$15.6K Sell
12,900
-15,200
-54% -$19.3K ﹤0.01% 12935
2023
Q1
$35.4K Sell
28,100
-13,300
-32% -$21.7K ﹤0.01% 12567
2022
Q4
$77K Buy
41,400
+27,500
+198% +$53.8K ﹤0.01% 11568
2022
Q3
$27K Sell
13,900
-4,100
-23% -$9.2K ﹤0.01% 11959
2022
Q2
$37K Sell
18,000
-162,500
-90% -$522K ﹤0.01% 12116
2022
Q1
$827K Sell
180,500
-108,300
-38% -$604K ﹤0.01% 8145
2021
Q4
$1.86M Buy
288,800
+84,600
+41% +$507K ﹤0.01% 6423
2021
Q3
$1.26M Buy
204,200
+127,500
+166% +$877K ﹤0.01% 7537
2021
Q2
$614K Buy
76,700
+36,500
+91% +$304K ﹤0.01% 9563
2021
Q1
$388K Buy
+40,200
New +$369K ﹤0.01% 10261
2017
Q3
Sell
-10,900
Closed -$59K 8151
2017
Q2
$59K Buy
+10,900
New +$57.3K ﹤0.01% 7058
2017
Q1
Sell
-11,700
Closed -$54K 8155
2016
Q4
$54K Hold
11,700
﹤0.01% 6851
2016
Q3
$65K Buy
11,700
+200
+2% +$916 ﹤0.01% 6791
2016
Q2
$45K Sell
11,500
-3,100
-21% -$15.3K ﹤0.01% 6434
2016
Q1
$75K Sell
14,600
-4,400
-23% -$28.7K ﹤0.01% 6143
2015
Q4
$170K Buy
19,000
+17,100
+900% +$616K ﹤0.01% 6011
2015
Q3
$73K Sell
1,900
-1,500
-44% -$74.1K ﹤0.01% 7267
2015
Q2
$157K Sell
3,400
-6,000
-64% -$240K ﹤0.01% 6616
2015
Q1
$354K Buy
9,400
+1,100
+13% +$43.7K ﹤0.01% 5421
2014
Q4
$334K Buy
+8,300
New +$281K ﹤0.01% 5274

Other funds holding CMRX

Citadel Advisors's CMRX Position: Q2 2025 in Review

Citadel Advisors sold out of Chimerix, Inc. (CMRX) in Q2 2025, closing a stake of 82,989 shares — an estimated $706K sold.

Citadel Advisors first reported a position in CMRX in Q4 2013 and held it in 46 quarters. The position peaked at $28.3M in Q1 2015. 1 fund tracked by Wall St. Rank holds CMRX as of Q2 2025.

  • Citadel Advisors reported no remaining Chimerix, Inc. position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 82,989 Chimerix, Inc. shares in Q2 2025, an estimated $706K.
  • Citadel Advisors first reported a position in Chimerix, Inc. in Q4 2013 and held it in 46 quarters.
  • Citadel Advisors's Chimerix, Inc. position peaked at $28.3M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.